Cyclin B3 promotes anaphase i onset in oocyte meiosis

M.E. Karasu, N. Bouftas, S. Keeney, K. Wassmann

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

© 2019 Karasu et al.Meiosis poses unique challenges because two rounds of chromosome segregation must be executed without intervening DNA replication. Mammalian cells express numerous temporally regulated cyclins, but how these proteins collaborate to control meiosis remains poorly understood. Here, we show that female mice genetically ablated for cyclin B3 are viable-indicating that the protein is dispensable for mitotic divisions-but are sterile.Mutant oocytes appear normal until metaphase I but then display a highly penetrant failure to transition to anaphase I. They arrest with hallmarks of defective anaphase-promoting complex/cyclosome (APC/C) activation, including no separase activity, high CDK1 activity, and high cyclin B1 and securin levels. Partial APC/C activation occurs, however, as exogenously expressed APC/C substrates can be degraded. Cyclin B3 forms active kinase complexes with CDK1, and meiotic progression requires cyclin B3-associated kinase activity. Cyclin B3 homologues from frog, zebrafish, and fruit fly rescue meiotic progression in cyclin B3-deficient mouse oocytes, indicating conservation of the biochemical properties and possibly cellular functions of this germline-critical cyclin.
Original languageEnglish
Pages (from-to)1265-1281
JournalJournal of Cell Biology
Volume218
Issue number4
DOIs
Publication statusPublished - 2019
Externally publishedYes

Funding

MSKCC core facilities were supported by National Institutes of Health grant P30 CA008748. N. Bouftas is supported by a fellowship from the French Ministère de la Recherche, and a fellowship from the Fondation ARC pour la Recherche sur le Cancer. Work in the Wassmann laboratory was financed by the Fondation pour la Recherche Médicale grant Equipe DEQ20160334921 and Agence Nationale de la Recherche grant ANR-16-CE92-0007-01 (to K. Wassmann) and core funding from Université Pierre et Marie Curie and the Centre National de la Recherche Scientifique. Work in the Keeney laboratory was supported by the Howard Hughes Medical Institute. The authors declare no competing financial interests. Author contributions: M. Karasu generated the Ccnb3–/– mouse strain and cloned plasmids used in this study, unless otherwise noted, and performed experiments in Figs. 1 (A–C), 3 C, and 6 A. Experiments in Figs. 4 (A and B), 6 (B and C), and 7 (A and B) were performed by N. Bouftas, and kinase assays in Figs. 3 D and 6 C by N. Bouftas and K. Wassmann. The remaining experiments and statistical analysis were done by N. Bouftas and M. Karasu. Overall supervision, funding acquisition, and project administration were done by K. Wassmann and S. Keeney. Figures were prepared by N. Bouftas, M. Karasu, and K. Wassmann, and the manuscript was written by K. Wassmann and S. Keeney with substantial input from other authors.

FundersFunder number
French Ministère de la Recherche
National Institutes of Health
Howard Hughes Medical Institute
National Cancer InstituteP30CA008748
Agence Nationale de la RechercheANR-16-CE92-0007-01
Fondation pour la Recherche MédicaleDEQ20160334921
Fondation ARC pour la Recherche sur le Cancer
Centre National de la Recherche Scientifique
Université Pierre et Marie Curie

    Fingerprint

    Dive into the research topics of 'Cyclin B3 promotes anaphase i onset in oocyte meiosis'. Together they form a unique fingerprint.

    Cite this